Prediction: Why We See ON Semiconductor Hitting a New All-Time High This Year

onsemi (NASDAQ:ON) has staged a singular comeback successful the semiconductor assemblage this year, and our proprietary exemplary says the rally has country to run. After bottoming beneath $41 past spring, the banal has reclaimed the $100 grip arsenic investors terms successful a cyclical betterment and AI information halfway powerfulness demand.

Our 24/7 Wall St. Price Target for onsemi

The banal trades astatine $106.02 arsenic of May 19, 2026. Our 24/7 Wall St. terms people for onsemi is $133.41, implying 25.84% upside implicit the adjacent 12 months. We complaint shares a bargain with 90% confidence.

From $44 to $106 successful a Year

Shares are up 141.83% implicit the past twelvemonth and 95.79% twelvemonth to date, with a 27.72% one-month surge powering the move. The banal sits astir 13% beneath its 52-week precocious of $119.10, good supra the $40.62 low.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks. Get them present FREE.

Q4 2025 delivered non-GAAP EPS of $0.64 connected gross of $1,530.1M, beating EPS estimates portion narrowly missing expectations connected the apical line. Full-year escaped currency travel deed a grounds $1,418.6M, and absorption authorized a caller $6B buyback implicit 3 years.

The Case for $148 and Beyond

Bulls spot onsemi arsenic a leveraged play connected conveyance electrification, AI information halfway power, and concern automation. The motorboat of vertical GaN (vGaN) powerfulness semiconductors, the MoU with Innoscience for 200mm GaN-on-silicon, and the GlobalFoundries collaboration connected 650V GaN presumption the institution astatine the cutting borderline of next-generation power. The EliteSiC M3e plan triumph wrong Xiaomi's EV SUV underscores automotive traction.

The bull script points to $148.38 implicit the adjacent year, a 39.95% full return, if gross margins re-expand toward 42% and Power Solutions returns to growth.

What Could Go Wrong

The carnivore lawsuit starts with valuation. The P/E sits astatine 340, and implied guardant P/E is 45. FY2025 nett income collapsed 92.31% to $121M, and each 3 segments declined treble digits successful Q4. Barclays initiated sum astatine equal-weight with a $75 terms target, citing automotive and China exposure.